TRILC Turk Ilac Ve Serum Sanayi Anonim Sirketi
Turk Ilac Ve Serum Sanayi Anonim Sirketi produces and sells human tablets, capsules, ampoules, vials, ointments-creams, intravenous serums, parenteral solutions, nutritional solutions, amino acids, and other chemicals in Turkey. It also offers bulb, biological, and serum products, as well as medical devices. Turk Ilac Ve Serum Sanayi Anonim Sirketi was founded in 2010 and is headquartered in Ankara, Turkey.…
Industry Peers
Drug Manufacturers - Specialty & GenericKey Statistics
About Turk Ilac Ve Serum Sanayi Anonim Sirketi (IST: TRILC)
›
Turk Ilac Ve Serum Sanayi Anonim Sirketi (IST: TRILC) is listed on Borsa Istanbul, where its shares trade in TRY. It belongs to the Drug Manufacturers - Specialty & Generic industry, part of the Healthcare sector, and reports about 520 employees.
The shares were at 0.7100 TRY on 19 November 2026, down 75.4% over 52 weeks. Its 52-week range is 0.6800 TRY to 4.400 TRY: the price is 83.9% below the high and 4.4% above the low.
At a market capitalisation of 736.27M TRY, it trades at 7.9 times trailing earnings. The median trailing P/E of its 17 largest Drug Manufacturers - Specialty & Generic peers is 24.7, a discount of 68% for TRILC.
Turk Ilac Ve Serum Sanayi Anonim Sirketi reports return on equity of -38.4%, an operating margin of 16.8% and revenue down 56.1% year over year.
Its debt exceeds its cash by 1.15B TRY, a debt-to-equity ratio of 2.08. Its Piotroski F-score is 5 out of 9, an average reading of its financial health.